Summary of antibody screening of patients treated with DARA
Patient | Antibody Screen With Untreated Reagent Cells (AHG Phase) | Antibody Screen With DTT-treated Reagent Cells (AHG Phase) | Autocontrol | ||
|---|---|---|---|---|---|
| 1 | SC I | 1+ | SC I | Negative | Negative |
| SC II | 1+ | SC II | Negative | ||
| SC III | 1+ | SC III | Negative | ||
| 2 | SC I | 1+ | SC I | Negative | Negative |
| SC II | Negative | SC II | Negative | ||
| SC III | 1+ | SC III | Negative | ||
| 3 | SC I | Negative | SC I | Negative | Negative |
| SC II | Weak | SC II | Negative | ||
| SC III | 1+ | SC III | Negative | ||
| 4 | SC I | 1+ | SC I | Negative | Negative |
| SC II | 1+ | SC II | Negative | ||
| SC III | 1+ | SC III | Negative | ||
SC, screening cell.